Results for Tumor Necrosis Factor (TNF) Alpha Inhibitor

A combination of aerobic exercise and resistance training was effective in reducing inflammation.

Article Published Date : Mar 01, 2017
Study Type : Human Study
Additional Links
Diseases : Inflammation : CK(9572) : AC(3089), Postmenopausal Complications
Therapeutic Actions : Exercise: Aerobic : CK(663) : AC(92), Exercise: Resistance Training : CK(547) : AC(63)
Pharmacological Actions : Anti-Inflammatory Agents : CK(20859) : AC(8334), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815)
Additional Keywords : Anti-Inflammatory Agents, Exercise: Aerobic, Exercise: Resistance Training, Inflammation : CK(128) : AC(57), Postmenopausal Complications : CK(30) : AC(2), Tumor Necrosis Factor (TNF) Alpha Inhibitor

Baicalein could be a lead compound for the modulation of inflammatory diseases as well as certain cancers.

Article Published Date : Oct 31, 2016
Study Type : In Vitro Study
Additional Links
Substances : Baicalein : CK(184) : AC(112)
Diseases : Cervical Cancer : CK(756) : AC(422), Inflammation : CK(9572) : AC(3089)
Pharmacological Actions : Anti-Inflammatory Agents : CK(20859) : AC(8334), NF-kappaB Inhibitor : CK(3536) : AC(2098), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815)
Additional Keywords : Anti-Inflammatory Agents, Baicalein, Cervical Cancer, Gene Expression Regulation : CK(1141) : AC(501), NF-kappaB Inhibitor, Tumor Necrosis Factor (TNF) Alpha Inhibitor

Docosahexaenoic acid might influence the process of oligodendrocyte progenitor maturation.

Article Published Date : Jun 20, 2017
Study Type : In Vitro Study
Additional Links
Substances : DHA (Docosahexaenoic Acid) : CK(1117) : AC(204)
Diseases : Demyelinating Diseases : CK(2740) : AC(589), Multiple Sclerosis : CK(1802) : AC(394)
Pharmacological Actions : Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815)
Additional Keywords : Demyelinating Diseases, DHA (Docosahexaenoic Acid), Multiple Sclerosis : CK(10) : AC(1), Tumor Necrosis Factor (TNF) Alpha Inhibitor

Lactobacillus plantarum alleviates aflatoxins B1 and M1 induced disturbances in the intestinal genes expression and DNA fragmentation.

Article Published Date : Mar 20, 2018
Study Type : Animal Study
Additional Links
Substances : Lactobacillus plantarum : CK(674) : AC(194)
Diseases : DNA damage : CK(1997) : AC(713)
Pharmacological Actions : Genoprotective : CK(477) : AC(177), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815)
Additional Keywords : DNA damage, Gene Expression Regulation : CK(1141) : AC(501), Genoprotective, Lactobacillus plantarum, Tumor Necrosis Factor (TNF) Alpha Inhibitor
Problem Substances : Aflatoxin : CK(56) : AC(8)

Lycopene has a protective effect on non-alcoholic fatty liver disease.

Article Published Date : Dec 13, 2016
Study Type : Animal Study
Additional Links
Substances : Lycopene : CK(886) : AC(249)
Diseases : Nonalcoholic fatty liver disease (NAFLD) : CK(1862) : AC(521)
Pharmacological Actions : Antioxidants : CK(21528) : AC(8856), Hepatoprotective : CK(5098) : AC(2264), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815)
Additional Keywords : Antioxidants : CK(303) : AC(126), Dose Response : CK(1712) : AC(683), Hepatoprotective, lycopene, Nonalcoholic fatty liver disease (NAFLD), Tumor Necrosis Factor (TNF) Alpha Inhibitor

Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.

Article Published Date : Mar 19, 2018
Study Type : In Vitro Study
Additional Links
Substances : Puerarin : CK(547) : AC(270)
Diseases : Lipopolysaccharide-Induced Toxicity : CK(1764) : AC(1073), Lung Injury: Acute : CK(321) : AC(159)
Pharmacological Actions : Anti-Inflammatory Agents : CK(20859) : AC(8334), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815)
Additional Keywords : Anti-Inflammatory Agents, Lipopolysaccharide-Induced Toxicity, Lung Injury: Acute, Puerarin, Tumor Necrosis Factor (TNF) Alpha Inhibitor

Puerarin treatment may represent a novel approach to lowering the risk of or improving function in ischemia-reperfusion brain injury-related disorders.

Article Published Date : Jan 18, 2009
Study Type : Animal Study
Additional Links
Substances : Puerarin : CK(547) : AC(270)
Diseases : Brain Ischemia : CK(341) : AC(151), Middle Cerebral Artery Occlusion (MCAO) : CK(109) : AC(47)
Pharmacological Actions : Antioxidants : CK(21528) : AC(8856), Neuroprotective Agents : CK(10404) : AC(4396), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(6736) : AC(2815), Vasodilator Agents : CK(626) : AC(169)
Additional Keywords : Antioxidants : CK(303) : AC(126), Brain Ischemia, Middle Cerebral Artery Occlusion (MCAO), Neuroprotective Agents, Tumor Necrosis Factor (TNF) Alpha Inhibitor, Vasodilator Agents

Connect with GreenMedInfo

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2023 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.